{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:14:57Z","timestamp":1791346497430,"version":"4.3.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-71194-5","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:36:33Z","timestamp":1774690593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modulating nuclear stiffness and envelope barrier facilitates AAV nuclear entry and reduces immunogenicity"],"prefix":"10.1038","volume":"17","author":[{"given":"Yangsen","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3105-336X","authenticated-orcid":false,"given":"Fuhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangsheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0218-1664","authenticated-orcid":false,"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"71194_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358\u2013378 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"71194_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","volume":"8","author":"P Colella","year":"2018","unstructured":"Colella, P., Ronzitti, G. & Mingozzi, F. Emerging issues in AAV-mediated in vivo gene therapy. Mol. Ther. Methods Clin. Dev. 8, 87\u2013104 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"71194_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/hum.2018.015","volume":"29","author":"C Hinderer","year":"2018","unstructured":"Hinderer, C. et al. Severe Toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum. Gene Ther. 29, 285\u2013298 (2018).","journal-title":"Hum. Gene Ther."},{"key":"71194_CR4","doi-asserted-by":"crossref","unstructured":"Large, E. E., Silveria, M. A., Zane, G. M., Weerakoon, O. & Chapman, M. S. Adeno-Associated Virus (AAV) gene delivery: dissecting molecular interactions upon cell entry. Viruses 13, 1336 (2021).","DOI":"10.3390\/v13071336"},{"key":"71194_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang, J. H., Gessler, D. J., Zhan, W., Gallagher, T. L. & Gao, G. Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal. Transduct. Target Ther. 9, 78 (2024).","journal-title":"Signal. Transduct. Target Ther."},{"key":"71194_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107453","volume":"207","author":"NF Nidetz","year":"2020","unstructured":"Nidetz, N. F. et al. Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery. Pharm. Ther. 207, 107453 (2020).","journal-title":"Pharm. Ther."},{"key":"71194_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nm1358","volume":"12","author":"CS Manno","year":"2006","unstructured":"Manno, C. S. et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342\u2013347 (2006).","journal-title":"Nat. Med."},{"key":"71194_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd9776","volume":"374","author":"CE Zimmerli","year":"2021","unstructured":"Zimmerli, C. E. et al. Nuclear pores dilate and constrict in cellulo. Science 374, eabd9776 (2021).","journal-title":"Science"},{"key":"71194_CR9","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1021\/ac200401n","volume":"83","author":"KW Liu","year":"2011","unstructured":"Liu, K. W. & Biswal, S. L. Probing insertion and solubilization effects of lysolipids on supported lipid bilayers using microcantilevers. Anal. Chem. 83, 4794\u20134801 (2011).","journal-title":"Anal. Chem."},{"key":"71194_CR10","doi-asserted-by":"publisher","first-page":"8505","DOI":"10.1021\/bi900951r","volume":"48","author":"Y Lange","year":"2009","unstructured":"Lange, Y., Ye, J., Duban, M. E. & Steck, T. L. Activation of membrane cholesterol by 63 amphipaths. Biochemistry 48, 8505\u20138515 (2009).","journal-title":"Biochemistry"},{"key":"71194_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201906508","volume":"32","author":"H Madry","year":"2020","unstructured":"Madry, H. et al. Thermosensitive hydrogel based on PEO-PPO-PEO poloxamers for a controlled in situ release of recombinant adeno-associated viral vectors for effective gene therapy of cartilage defects. Adv. Mater. 32, e1906508 (2020).","journal-title":"Adv. Mater."},{"key":"71194_CR12","first-page":"3085","volume":"17","author":"H Shu","year":"2019","unstructured":"Shu, H. et al. Addition of free poloxamer 407 to a new gene vector P407-PEI-K12 solution forms a sustained-release in situ hypergel that enhances cell transfection and extends gene expression. Oncol. Lett. 17, 3085\u20133096 (2019).","journal-title":"Oncol. Lett."},{"key":"71194_CR13","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1093\/emboj\/21.11.2664","volume":"21","author":"K Ribbeck","year":"2002","unstructured":"Ribbeck, K. & G\u00f6rlich, D. The permeability barrier of nuclear pore complexes appears to operate via hydrophobic exclusion. EMBO J. 21, 2664\u20132671 (2002).","journal-title":"EMBO J."},{"key":"71194_CR14","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.nmd.2023.09.008","volume":"33","author":"L Servais","year":"2023","unstructured":"Servais, L., Horton, R., Saade, D., Bonnemann, C. & Muntoni, F. 261st ENMC International Workshop: management of safety issues arising following AAV gene therapy. 17th-19th June 2022, Hoofddorp, The Netherlands. Neuromuscul. Disord. 33, 884\u2013896 (2023).","journal-title":"Neuromuscul. Disord."},{"key":"71194_CR15","doi-asserted-by":"crossref","unstructured":"Ilyinskii, P. O. et al. Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles. Sci. Adv. 7, eabd0321 (2021).","DOI":"10.1126\/sciadv.abd0321"},{"key":"71194_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06621-3","volume":"9","author":"A Meliani","year":"2018","unstructured":"Meliani, A. et al. Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration. Nat. Commun. 9, 4098 (2018).","journal-title":"Nat. Commun."},{"key":"71194_CR17","first-page":"169","volume":"10","author":"K Budde","year":"2005","unstructured":"Budde, K. et al. Pharmacokinetics of the immunosuppressant everolimus in maintenance renal transplant patients. Eur. J. Med. Res. 10, 169\u2013174 (2005).","journal-title":"Eur. J. Med. Res."},{"key":"71194_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202307366","volume":"20","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Transdermal microneedles alleviated rheumatoid arthritis by inducing immune tolerance via skin-resident antigen presenting cells. Small 20, e2307366 (2024).","journal-title":"Small"},{"key":"71194_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu, N. & Takayanagi, H. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat. Rev. Rheumatol. 18, 415\u2013429 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"71194_CR20","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292\u2013304 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"71194_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41577-019-0178-8","volume":"19","author":"M Tsukasaki","year":"2019","unstructured":"Tsukasaki, M. & Takayanagi, H. Osteoimmunology: evolving concepts in bone\u2013immune interactions in health and disease. Nat. Rev. Immunol. 19, 626\u2013642 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"71194_CR22","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha, D. & Smolen, J. S. Diagnosis and management of rheumatoid arthritis: a review. JAMA 320, 1360\u20131372 (2018).","journal-title":"JAMA"},{"key":"71194_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett, G. & Gravallese, E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat. Rev. Rheumatol. 8, 656\u2013664 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"71194_CR24","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott, D. L., Wolfe, F. & Huizinga, T. W. Rheumatoid arthritis. Lancet 376, 1094\u20131108 (2010).","journal-title":"Lancet"},{"key":"71194_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","volume":"130","author":"T Nakamura","year":"2007","unstructured":"Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811\u2013823 (2007).","journal-title":"Cell"},{"key":"71194_CR26","first-page":"612","volume":"68","author":"HD Nelson","year":"2003","unstructured":"Nelson, H. D. Postmenopausal osteoporosis and estrogen. Am. Fam. Phys. 68, 612 (2003).","journal-title":"Am. Fam. Phys."},{"key":"71194_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s12276-024-01157-7","volume":"56","author":"N Takegahara","year":"2024","unstructured":"Takegahara, N., Kim, H. & Choi, Y. Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases. Exp. Mol. Med. 56, 264\u2013272 (2024).","journal-title":"Exp. Mol. Med."},{"key":"71194_CR28","doi-asserted-by":"publisher","first-page":"108168","DOI":"10.1016\/j.pharmthera.2022.108168","volume":"237","author":"S Song","year":"2022","unstructured":"Song, S., Guo, Y., Yang, Y. & Fu, D. Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharm. Ther. 237, 108168 (2022).","journal-title":"Pharm. Ther."},{"key":"71194_CR29","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","volume":"18","author":"JX Li","year":"2022","unstructured":"Li, J. X. & Cummins, C. L. Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions. Nat. Rev. Endocrinol. 18, 540\u2013557 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"71194_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S8756-3282(01)00610-X","volume":"29","author":"D Patschan","year":"2001","unstructured":"Patschan, D., Loddenkemper, K. & Buttgereit, F. Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29, 498\u2013505 (2001).","journal-title":"Bone"},{"key":"71194_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature11000","volume":"485","author":"M Hayashi","year":"2012","unstructured":"Hayashi, M. et al. Osteoprotection by semaphorin 3A. Nature 485, 69\u201374 (2012).","journal-title":"Nature"},{"key":"71194_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrrheum.2017.201","volume":"14","author":"M Nishide","year":"2018","unstructured":"Nishide, M. & Kumanogoh, A. The role of semaphorins in immune responses and autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 14, 19\u201331 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"71194_CR33","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.cmet.2018.12.021","volume":"29","author":"M Hayashi","year":"2019","unstructured":"Hayashi, M. et al. Autoregulation of osteocyte Sema3A orchestrates estrogen action and counteracts bone aging. Cell Metab. 29, 627\u2013637.e625 (2019).","journal-title":"Cell Metab."},{"key":"71194_CR34","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/eji.200535601","volume":"36","author":"Y Lepelletier","year":"2006","unstructured":"Lepelletier, Y. et al. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur. J. Immunol. 36, 1782\u20131793 (2006).","journal-title":"Eur. J. Immunol."},{"key":"71194_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd4337","volume":"13","author":"T Worzfeld","year":"2014","unstructured":"Worzfeld, T. & Offermanns, S. Semaphorins and plexins as therapeutic targets. Nat. Rev. Drug Discov. 13, 603\u2013621 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"71194_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41591-021-01664-4","volume":"28","author":"TR Flotte","year":"2022","unstructured":"Flotte, T. R. et al. AAV gene therapy for Tay-Sachs disease. Nat. Med. 28, 251\u2013259 (2022).","journal-title":"Nat. Med."},{"key":"71194_CR37","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/S0140-6736(23)02874-X","volume":"403","author":"J Lv","year":"2024","unstructured":"Lv, J. et al. AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial. Lancet 403, 2317\u20132325 (2024).","journal-title":"Lancet"},{"key":"71194_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.omtm.2020.01.002","volume":"16","author":"G Yiu","year":"2020","unstructured":"Yiu, G. et al. Suprachoroidal and subretinal injections of AAV using transscleral microneedles for retinal gene delivery in nonhuman primates. Mol. Ther. Methods Clin. Dev. 16, 179\u2013191 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"71194_CR39","doi-asserted-by":"crossref","unstructured":"Khaliq, N. U., Lee, J., Kim, S., Sung, D. & Kim, H. Pluronic F-68 and F-127 based nanomedicines for advancing combination cancer therapy. Pharmaceutics 15, 2102 (2023).","DOI":"10.3390\/pharmaceutics15082102"},{"key":"71194_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2015.47","volume":"2","author":"JM Kelich","year":"2015","unstructured":"Kelich, J. M. et al. Super-resolution imaging of nuclear import of adeno-associated virus in live cells. Mol. Ther. Methods Clin. Dev. 2, 15047 (2015).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"71194_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.omtm.2020.08.006","volume":"18","author":"J Zhao","year":"2020","unstructured":"Zhao, J. et al. High-resolution histological landscape of AAV DNA distribution in cellular compartments and tissues following local and systemic injection. Mol. Ther. Methods Clin. Dev. 18, 856\u2013868 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"71194_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42187-5","volume":"14","author":"S Jiao","year":"2023","unstructured":"Jiao, S. et al. SUN1\/2 controls macrophage polarization via modulating nuclear size and stiffness. Nat. Commun. 14, 6416 (2023).","journal-title":"Nat. Commun."},{"key":"71194_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000369273","volume":"7","author":"GL Rogers","year":"2015","unstructured":"Rogers, G. L. et al. Unique roles of TLR9- and MyD88-dependent and -independent pathways in adaptive immune responses to AAV-mediated gene transfer. J. Innate Immun. 7, 302\u2013314 (2015).","journal-title":"J. Innate Immun."},{"key":"71194_CR44","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1172\/JCI37607","volume":"119","author":"J Zhu","year":"2009","unstructured":"Zhu, J., Huang, X. & Yang, Y. The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J. Clin. Investig. 119, 2388\u20132398 (2009).","journal-title":"J. Clin. Investig."},{"key":"71194_CR45","doi-asserted-by":"publisher","first-page":"66270","DOI":"10.18632\/oncotarget.19915","volume":"8","author":"Y Teng","year":"2017","unstructured":"Teng, Y. et al. Adenovirus-mediated delivery of Sema3A alleviates rheumatoid arthritis in a serum-transfer induced mouse model. Oncotarget 8, 66270\u201366280 (2017).","journal-title":"Oncotarget"},{"key":"71194_CR46","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bone.2018.06.003","volume":"114","author":"K Yang","year":"2018","unstructured":"Yang, K., Miron, R. J., Bian, Z. & Zhang, Y. F. A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice. Bone 114, 40\u201349 (2018).","journal-title":"Bone"},{"key":"71194_CR47","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/annrheumdis-2016-210630","volume":"76","author":"MA Boutet","year":"2017","unstructured":"Boutet, M. A. et al. IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro. Ann. Rheum. Dis. 76, 1304\u20131312 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"71194_CR48","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.7150\/ijms.56760","volume":"18","author":"DS Yoon","year":"2021","unstructured":"Yoon, D. S. et al. Cellular and tissue selectivity of AAV serotypes for gene delivery to chondrocytes and cartilage. Int. J. Med Sci. 18, 3353\u20133360 (2021).","journal-title":"Int. J. Med Sci."},{"key":"71194_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1089\/hum.2006.174","volume":"18","author":"MC Boissier","year":"2007","unstructured":"Boissier, M. C. et al. Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype. Hum. Gene Ther. 18, 525\u2013535 (2007).","journal-title":"Hum. Gene Ther."},{"key":"71194_CR50","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.apsb.2022.07.004","volume":"13","author":"F Wu","year":"2023","unstructured":"Wu, F. et al. Single-shot AAV-vectored vaccine against SARS-CoV-2 with fast and long-lasting immunity. Acta Pharm. Sin. B 13, 2219\u20132233 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"71194_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10809-6","volume":"10","author":"Y-S Yang","year":"2019","unstructured":"Yang, Y.-S. et al. Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat. Commun. 10, 2958 (2019).","journal-title":"Nat. Commun."},{"key":"71194_CR52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi, H. et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 408, 600\u2013605 (2000).","journal-title":"Nature"},{"key":"71194_CR53","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","volume":"203","author":"K Sato","year":"2006","unstructured":"Sato, K. et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673\u20132682 (2006).","journal-title":"J. Exp. Med."},{"key":"71194_CR54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","volume":"21","author":"C Li","year":"2020","unstructured":"Li, C. & Samulski, R. J. Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 21, 255\u2013272 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"71194_CR55","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1038\/mt.2010.170","volume":"18","author":"PE Monahan","year":"2010","unstructured":"Monahan, P. E. et al. Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application. Mol. Ther. 18, 1907\u20131916 (2010).","journal-title":"Mol. Ther."},{"key":"71194_CR56","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ymthe.2004.07.018","volume":"10","author":"L Zhong","year":"2004","unstructured":"Zhong, L. et al. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo. Mol. Ther. 10, 950\u2013957 (2004).","journal-title":"Mol. Ther."},{"key":"71194_CR57","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1128\/JVI.77.4.2741-2746.2003","volume":"77","author":"K Qing","year":"2003","unstructured":"Qing, K. et al. Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo. J. Virol. 77, 2741\u20132746 (2003).","journal-title":"J. Virol."},{"key":"71194_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2014.33","volume":"1","author":"M Corti","year":"2014","unstructured":"Corti, M. et al. B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study. Mol. Ther. Methods Clin. Dev. 1, 14033 (2014).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"71194_CR59","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1517\/14712598.2015.1035645","volume":"15","author":"LV Tse","year":"2015","unstructured":"Tse, L. V., Moller-Tank, S. & Asokan, A. Strategies to circumvent humoral immunity to adeno-associated viral vectors. Expert Opin. Biol. Ther. 15, 845\u2013855 (2015).","journal-title":"Expert Opin. Biol. Ther."},{"key":"71194_CR60","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4161\/nucl.24874","volume":"4","author":"W Yang","year":"2013","unstructured":"Yang, W. Distinct, but not completely separate spatial transport routes in the nuclear pore complex. Nucleus 4, 166\u2013175 (2013).","journal-title":"Nucleus"},{"key":"71194_CR61","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1126\/science.1142204","volume":"318","author":"LJ Terry","year":"2007","unstructured":"Terry, L. J., Shows, E. B. & Wente, S. R. Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 318, 1412\u20131416 (2007).","journal-title":"Science"},{"key":"71194_CR62","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1083\/jcb.149.5.1027","volume":"149","author":"N Shulga","year":"2000","unstructured":"Shulga, N., Mosammaparast, N., Wozniak, R. & Goldfarb, D. S. Yeast nucleoporins involved in passive nuclear envelope permeability. J. Cell Biol. 149, 1027\u20131038 (2000).","journal-title":"J. Cell Biol."},{"key":"71194_CR63","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1128\/JVI.02660-13","volume":"88","author":"SC Nicolson","year":"2014","unstructured":"Nicolson, S. C. & Samulski, R. J. Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus. J. Virol. 88, 4132\u20134144 (2014).","journal-title":"J. Virol."},{"key":"71194_CR64","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1038\/emboj.2009.200","volume":"28","author":"D Mohr","year":"2009","unstructured":"Mohr, D., Frey, S., Fischer, T., G\u00fcttler, T. & G\u00f6rlich, D. Characterisation of the passive permeability barrier of nuclear pore complexes. EMBO J. 28, 2541\u20132553 (2009).","journal-title":"EMBO J."},{"key":"71194_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202412430","volume":"37","author":"F Wu","year":"2025","unstructured":"Wu, F. et al. A universal therapeutic vaccine leveraging autologous pre-existing immunity to eliminate in situ uniformly engineered heterogeneous tumor cells. Adv. Mater. 37, e2412430 (2025).","journal-title":"Adv. Mater."},{"key":"71194_CR66","doi-asserted-by":"publisher","first-page":"925503","DOI":"10.3389\/fimmu.2022.925503","volume":"13","author":"A Saalbach","year":"2022","unstructured":"Saalbach, A. & Kunz, M. Impact of chronic inflammation in psoriasis on bone metabolism. Front Immunol. 13, 925503 (2022).","journal-title":"Front Immunol."},{"key":"71194_CR67","doi-asserted-by":"crossref","unstructured":"Rella, V., Rotondo, C., Altomare, A., Cantatore, F. P. & Corrado, A. Bone involvement in systemic lupus erythematosus. Int. J. Mol. Sci. 23, 5804 (2022).","DOI":"10.3390\/ijms23105804"},{"key":"71194_CR68","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1016\/j.ymthe.2023.10.015","volume":"31","author":"D Duan","year":"2023","unstructured":"Duan, D. Lethal immunotoxicity in high-dose systemic AAV therapy. Mol. Ther. 31, 3123\u20133126 (2023).","journal-title":"Mol. Ther."},{"key":"71194_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48221-4","volume":"15","author":"S Luo","year":"2024","unstructured":"Luo, S. et al. An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species. Nat. Commun. 15, 3780 (2024).","journal-title":"Nat. Commun."},{"key":"71194_CR70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.apsb.2023.06.006","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Combination of AAV-delivered tumor suppressor PTEN with anti-PD-1 loaded depot gel for enhanced antitumor immunity. Acta Pharm. Sin. B 14, 350\u2013364 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"71194_CR71","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1021\/acs.nanolett.0c05110","volume":"21","author":"C Li","year":"2021","unstructured":"Li, C. et al. Nanoemulsions target to ectopic lymphoids in inflamed joints to restore immune tolerance in rheumatoid arthritis. Nano Lett. 21, 2551\u20132561 (2021).","journal-title":"Nano Lett."},{"key":"71194_CR72","doi-asserted-by":"crossref","unstructured":"He, C. et al. Rectifying the crosstalk between the skeletal and immune systems improves osteoporosis treatment by core-shell nanocapsules. ACS Nano 19, 5549\u20135567 (2025).","DOI":"10.1021\/acsnano.4c14728"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71194-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71194-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71194-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:08:40Z","timestamp":1779354520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-71194-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["71194"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-71194-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4549"}}